Related references
Note: Only part of the references are listed.Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Mieczyslaw Dutka et al.
HEART FAILURE REVIEWS (2022)
Emerging roles of fibroblasts in cardiovascular calcification
Wudi Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Serum osteoprotegerin levels, endothelial function and carotid intima-media thickness in type 2 diabetic patients
Mutlu Gunes et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2021)
Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis
Saba Abdi et al.
GENES (2021)
Cardiovascular Calcification as a Marker of Increased Cardiovascular Risk and a Surrogate for Subclinical Atherosclerosis: Role of Echocardiography
Andrea Faggiano et al.
JOURNAL OF CLINICAL MEDICINE (2021)
High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome
Mirthe Dekker et al.
SCIENTIFIC REPORTS (2021)
Association between Serum Osteoprotegerin Levels and Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction
Yves Cottin et al.
JOURNAL OF CLINICAL MEDICINE (2021)
HLA Allele and Haplotype Frequencies in Three Urban Mexican Populations: Genetic Diversity for the Approach of Genomic Medicine
Alma D. Del Angel-Pablo et al.
DIAGNOSTICS (2020)
The immunogenetic diversity of the HLA system in Mexico correlates with underlying population genetic structure
Rodrigo Barquera et al.
HUMAN IMMUNOLOGY (2020)
Genetic Variants and Haplotypes inOPGGene Are Associated with Premature Coronary Artery Disease and Traditional Cardiovascular Risk Factors in Mexican Population: The GEA Study
Nonanzit Perez-Hernandez et al.
DNA AND CELL BIOLOGY (2020)
Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?
Cristina Strobescu-Ciobanu et al.
ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY (2020)
Association of serum osteoprotegerin and osteoprotegerin gene polymorphism with subclinical carotid artery atherosclerosis and disease activity in rheumatoid arthritis patients
Eman A. M. Alkady et al.
EGYPTIAN RHEUMATOLOGIST (2020)
Cardiac calcification as a marker of subclinical atherosclerosis and predictor of cardiovascular events: A review of the evidence
Pompilio Faggiano et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
Jose Pablo Miramontes-Gonzalez et al.
ATHEROSCLEROSIS (2019)
The Role of Osteoprotegerin in Vascular Calcification and Bone Metabolism: The Basis for Developing New Therapeutics
Luc Rochette et al.
CALCIFIED TISSUE INTERNATIONAL (2019)
Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification
Marcin Krzanowski et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2018)
Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus
A. N. Kiani et al.
LUPUS (2017)
The association between OPG rs3102735 gene polymorphism, microembolic signal and stroke severity in acute ischemic stroke patients
Hongqin Zhao et al.
GENE (2017)
Association of the 1148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study
Rosalinda Posadas-Sanchez et al.
IMMUNOBIOLOGY (2017)
Differential expression of osteopontin, and osteoprotegerin mRNA in epicardial adipose tissue between patients with severe coronary artery disease and aortic valvular stenosis: association with HDL subclasses
Maria Luna-Luna et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Polymorphism rs2073618 of the osteoprotegerin gene as a potential marker of subclinical carotid atherosclerosis in Caucasians with type 2 diabetes mellitus
Ales Pleskovic et al.
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE (2017)
Prevalence and extent of coronary artery calcification in an asymptomatic cardiovascular Mexican population: Genetics of Atherosclerotic Disease study
Carlos Posadas-Romero et al.
ARCHIVOS DE CARDIOLOGIA DE MEXICO (2017)
Aortic valve calcification prevalence and association with coronary risk factors and atherosclerosis in Mexican population
Jorge Acuna-Valerio et al.
ARCHIVOS DE CARDIOLOGIA DE MEXICO (2017)
Role of adiponectin and free fatty acids on the association between abdominal visceral fat and insulin resistance
Aida Medina-Urrutia et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Distribution of Alkaline Phosphatase, Osteopontin, RANK Ligand and Osteoprotegerin in Calcified Human Carotid Atheroma
Catherine L. Higgins et al.
PROTEIN JOURNAL (2015)
Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification
Carmen Perez de Ciriza et al.
CLINICAL BIOCHEMISTRY (2014)
The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients
M. Hakimi et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
The ABCA1 Gene R230C Variant Is Associated with Decreased Risk of Premature Coronary Artery Disease: The Genetics of Atherosclerotic Disease (GEA) Study
Teresa Villarreal-Molina et al.
PLOS ONE (2012)
Population Structure and Paternal Admixture Landscape on Present-Day Mexican-Mestizos Revealed by Y-STR Haplotypes
J. Salazar-Flores et al.
AMERICAN JOURNAL OF HUMAN BIOLOGY (2010)
SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies
Zongli Xu et al.
NUCLEIC ACIDS RESEARCH (2009)
An Emerging Paradigm in Atherosclerosis: Focus on Subclinical Disease
Michael Miller
POSTGRADUATE MEDICINE (2009)
Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes
Baris Akinci et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Genetic admixture and diversity estimations in the Mexican Mestizo population from Mexico City using 15 STR polymorphic markers
Teresa Juarez-Cedillo et al.
FORENSIC SCIENCE INTERNATIONAL-GENETICS (2008)
The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans
Eun Jung Rhee et al.
CLINICAL ENDOCRINOLOGY (2006)
CCAAT/enhancer binding proteins and interferon signaling pathways
DV Kalvakolanu et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
Osteoprotegerin gene polymorphisms in men with coronary artery disease
M Soufi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
RANK ligand and osteoprotegerin - Paracrine regulators of bone metabolism and vascular function
M Schoppet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
PROMO:: detection of known transcription regulatory elements using species-tailored searches
X Messeguer et al.
BIOINFORMATICS (2002)
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis
H Min et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
